drugset / Trial / NCT03224468

Effect of Medical Marijuana on Neurocognition and Escalation of Use

NCT03224468

Completed 269 enrolled Massachusetts General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will use a randomized controlled design to test whether patients who use medical marijuana, compared to a waitlist control group, experience a change in health outcomes (relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use disorders, neurocognitive impairments) or brain-based changes.

Timeline

Start
2017-07-01
Primary completion
2021-02-05
Completion
2022-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified